New Frontiers in Migraine Management: Expert Insights from Dr Peter Goadsby, Neurologist

In conversation with Dr Peter Goadsby, Director of NIHR Clinical Research Facility and Professor of Neurology at King's College, London. Dr Peter leads the Biomedical Research Council Themes; Clinical Research Facility, and Pain and Headache.

He is also the National Lead for Neurological Disorders for the Clinical Research Network, NIHR UK, a Trustee of the Organisation for the Understanding of Cluster Headache (OUCH UK) and Chair of the Scientific Programme Committee, Migraine Trust International Symposium.

Dr Goadsby also leads the Pain and Addictions theme at the NIHR Maudsley Biomedical Research Centre. He talks about the burden of undiagnosed/diagnosed migraine globally, the effectiveness and tolerability of the current available treatments along with the challenges faced, the recent advances in the management of migraine.

He further discusses about pain reduction being a sign of clinical effectiveness and how early return to function is equally more important from a patient's perspective.

Furthermore, he emphasizes on the actions needed to enhance the healthcare ecosystem (clinician, patient, payor) for optimal migraine management and how is their experience with Gepant class of drugs, especially Rimegepant. Lastly, he speaks on his experience with Monoclonal Antibodies.